According to Research by SNS Insider, Global Laboratory Developed Tests Market Growth is Fueled by Rising Demand for Personalized Diagnostics and Chronic Disease Detection.Austin, Aug. 05, 2025 (GLOBE ...

The laboratory developed test market is expected to grow from US$ 4,524.75 Million in 2021 at a CAGR of 7.0% during the forecast period 2021 - 2028, to reach US$ 7,269.3 Million by 2028.

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory ...

Australia developed a light-touch approach starting in 2010, subjecting only the highest-risk laboratory-developed tests to external evaluation and tracking in a public registry. 10 For class I–III ...

Laboratory-developed tests have long skirted FDA oversight, though the agency has always maintained that it has the authority to step in. Debate over regulating the space stretches back to the ...

Quanterix’ LDT – the first pTau-181 plasma test released for clinical use in the U.S. – is a quantitative immunoassay intended for the measurement of pTau-181 concentration in human plasma.

VANCOUVER — Cannabix Technologies Inc. reports that Omega Laboratories Inc., a drug testing laboratory, has delivered a Validation Packet for Omega’s Laboratory Developed Test Method to test ...

Laboratory-Developed Tests (LDTs) Do Not Qualify as ‘Devices’ Under the Food, Drug and Cosmetic Act Reed Abrahamson, Joelle Groshek, Amy Johnson, Lance Lange, Joy Sharp, Hafsa Warsamee ...

This validation included a test method for the simultaneous quantification of Δ-9-tetrahydrocannabinol (THC), Δ-8-THC, cannabidiol (CBD), and cannabinol (CBN) in breath aerosols collected using ...